This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB03478/identifier/pdb/
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/resource/drugbank/drug/DB03478/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB03478/identifier/pubchem-substance/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03478/identifier/drugbank/

Statements

Subject Item
n2:DB03478
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB03478 n13:DB03478
dcterms:title
2'-O-Acetyl Adenosine-5-Diphosphoribose
adms:identifier
n6:46936692 n7:46505222 n10:DB03478 n11:OAD
n3:IUPAC-Name
n4:271B4C14-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4C1A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4C19-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4C16-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4C17-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4C18-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4C12-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4C10-363D-11E5-9242-09173F13E4C5 n4:271B4C13-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4C11-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4C20-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4C21-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4C1B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4C1C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4C1E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4C1D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4C1F-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4C26-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4C28-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4C29-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4C25-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4C24-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4C27-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4C15-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4C22-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4C23-363D-11E5-9242-09173F13E4C5